Phase II study of paclitaxel and cisplatin in combination with split course concomitant hyperfractionated re-irradiation in patients with recurrent squamous cell cancer of the head and neck
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Paclitaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 17 Nov 2015 Biomarkers information updated
- 17 Oct 2005 New trial record.